Femtech Canada wHealth MedPath Program

About

The wHealth MedPath program offers Canadian femtech companies the opportunity to access up to $20,000 in services aimed at advancing the commercialization of innovative women's health solutions, providing essential support in clinical validation, market strategy, and compliance pathways, with applications reviewed on a first-come, first-served basis until funding is fully committed.

Benefits

• Access to $20,000 worth in services to support commercialization of femtech solutions
• $5,000 product market assessment and up to $15,000 for commercialization projects with a 50% cash match required
• Specialized expertise in product development, clinical protocols, regulatory strategy, and compliance to accelerate market entry

Eligibility Criteria

• Privately incorporated Canadian femtech companies
• Working towards commercializing an innovative technology at Technology Readiness Level Six (TRL-6) or above
• Demonstrated commitment to commercializing innovation with a clear clinical application
• Must be an active member of Femtech Canada
• Ontario-based femtech firms must be a client of Innovation Factory

Target Region

Canada

Target Sector

Femtech